Segment & Geographic Data
Quant-Grade Normalized (live API)
API & CSV Delivery
Asp Isotopes Inc's Business Segments
Asp Isotopes Inc's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.
Reportable Segments
-
Largest Segment
-
Total Revenue
$ 5
Countrys Reported
2
Asp Isotopes Inc does not report a distinct business-segment axis in its filings - its disaggregated revenue is disclosed by product and service category instead. See the Product & Service breakdown below.
Revenue Share by Country -
- ZA66%
- US34%
Revenue by Geographic Country -
| Country | Revenue (Millions) | % of Total |
|---|---|---|
| ZA | $ 3 | 66% |
| US | $ 2 | 34% |
Revenue by Product & Service Category -
- Product88.3%
- Collaboration Revenue11.7%
Revenue by Product & Service Category -
| Category | Revenue (Millions) | % of Total |
|---|---|---|
| Product | $ 5 | 88.3% |
| Collaboration Revenue | $ 1 | 11.7% |
Product and service categories are a supplemental disclosure and are not required to sum to consolidated revenue or to the reportable segments above.
Description of Asp Isotopes Inc
Asp Isotopes Inc, also known as the Advanced Stable Isotope Products Isotopes Inc, is a leading company specializing in the production, distribution, and research of stable isotopes. With its headquarters located in a state-of-the-art facility in a major industrial complex, Asp Isotopes Inc has established itself as a prominent player in the stable isotope industry.
The company has a diverse portfolio of stable isotopes, including but not limited to carbon, nitrogen, oxygen, hydrogen, sulfur, and many more. These isotopes are produced through various methodologies, such as chemical separation, gas purification, and electrolytic processes, ensuring high purity and quality standards.
One of the highlights of Asp Isotopes Inc is its commitment to research and development. The company has a dedicated team of scientists and technicians who work tirelessly to explore new applications for stable isotopes across a wide range of industries. This includes the fields of pharmaceuticals, energy, environmental sciences, and biomedical research. They continuously collaborate with leading academic institutions and industrial partners to push the boundaries of stable isotope technology.
Asp Isotopes Inc takes pride in its state-of-the-art manufacturing facility, equipped with cutting-edge equipment and technologies. This enables them to produce isotopes of exceptional purity, meeting the stringent specifications and demands of their customers. The company adheres to strict quality control protocols, ensuring that each product batch undergoes rigorous testing to guarantee its authenticity and accuracy.
In addition to its production capabilities, Asp Isotopes Inc also offers comprehensive technical support and consultancy services. This includes assisting customers in determining the most suitable stable isotope for a particular application, providing guidance on handling and storage, and offering customized solutions based on individual requirements. The company's team of experts maintains close communication with clients, ensuring their needs are met with the utmost professionalism and efficiency.
Asp Isotopes Inc has built a strong global network of distributors, enabling them to supply their stable isotopes to customers worldwide. Their logistics team ensures timely and secure delivery, ensuring that the products reach their destinations in pristine condition. The company places great emphasis on customer satisfaction, aiming to provide exceptional service from the first contact to post-purchase support.
Overall, Asp Isotopes Inc stands as a leading force in the stable isotope industry, driven by its dedication to innovation, research, and customer satisfaction. With its extensive range of high-quality isotopes, advanced manufacturing capabilities, and commitment to scientific excellence, the company continues to contribute significantly to various fields by enabling groundbreaking research, driving technological advancements, and facilitating numerous industrial applications.
The company has a diverse portfolio of stable isotopes, including but not limited to carbon, nitrogen, oxygen, hydrogen, sulfur, and many more. These isotopes are produced through various methodologies, such as chemical separation, gas purification, and electrolytic processes, ensuring high purity and quality standards.
One of the highlights of Asp Isotopes Inc is its commitment to research and development. The company has a dedicated team of scientists and technicians who work tirelessly to explore new applications for stable isotopes across a wide range of industries. This includes the fields of pharmaceuticals, energy, environmental sciences, and biomedical research. They continuously collaborate with leading academic institutions and industrial partners to push the boundaries of stable isotope technology.
Asp Isotopes Inc takes pride in its state-of-the-art manufacturing facility, equipped with cutting-edge equipment and technologies. This enables them to produce isotopes of exceptional purity, meeting the stringent specifications and demands of their customers. The company adheres to strict quality control protocols, ensuring that each product batch undergoes rigorous testing to guarantee its authenticity and accuracy.
In addition to its production capabilities, Asp Isotopes Inc also offers comprehensive technical support and consultancy services. This includes assisting customers in determining the most suitable stable isotope for a particular application, providing guidance on handling and storage, and offering customized solutions based on individual requirements. The company's team of experts maintains close communication with clients, ensuring their needs are met with the utmost professionalism and efficiency.
Asp Isotopes Inc has built a strong global network of distributors, enabling them to supply their stable isotopes to customers worldwide. Their logistics team ensures timely and secure delivery, ensuring that the products reach their destinations in pristine condition. The company places great emphasis on customer satisfaction, aiming to provide exceptional service from the first contact to post-purchase support.
Overall, Asp Isotopes Inc stands as a leading force in the stable isotope industry, driven by its dedication to innovation, research, and customer satisfaction. With its extensive range of high-quality isotopes, advanced manufacturing capabilities, and commitment to scientific excellence, the company continues to contribute significantly to various fields by enabling groundbreaking research, driving technological advancements, and facilitating numerous industrial applications.
As of 2024, the registrant operated two segments: nuclear fuels, and specialist isotopes and related services. Following the acquisition of Skyline in August 2025, the registrant expanded to three segments: nuclear fuels; specialist isotopes and related services; and construction services.
The Nuclear Fuels segment focuses on research and development of technologies and methods for producing high-assay low-enriched uranium (HALEU) and Lithium-6 for advanced nuclear fuel markets. The Specialist Isotopes and Related Services segment develops technologies and methods to separate high-value, low-volume isotopes such as carbon-14 (C-14), silicon-28 (Si-28), and ytterbium-176 (Yb-176) for specialized markets including pharmaceuticals, agrochemicals, nuclear medical imaging, and semiconductors; this segment also includes PET Labs. The Construction Services segment provides public civil engineering services in Hong Kong, including road and drainage works, site clearing, demolition, concrete installation, excavation, and planting.
In early 2025, the registrant began commercial production of enriched isotopes at ASP enrichment facilities in Pretoria, South Africa. It targets commercial shipments of enriched C-14 and Si-28 in mid-2026 and the second quarter of 2026, respectively, and Yb-176 in mid-2026 or the third quarter of 2026. The registrant aims to demonstrate the capability to produce commercial quantities of enriched C-14, Si-28, and Yb-176 using ASP and QE technologies to address supply chain challenges, noting that Russia has historically been the sole supplier of C-14.